Literature DB >> 22093496

Laparoscopic hysterectomy versus abdominal hysterectomy for severe pelvic endometriosis.

Amphan Chalermchockchareonkit1, Putthawan Tekasakul, Pongsakdi Chaisilwattana, Korakot Sirimai, Noraziana Wahab.   

Abstract

OBJECTIVE: To compare the surgical outcomes of laparoscopic hysterectomy (LH) versus abdominal hysterectomy (AH) in patients with severe pelvic endometriosis.
METHODS: A retrospective review of patients undergoing hysterectomy for endometriosis was conducted between January 2002 and December 2007. A total of 503 patients had severe pelvic endometriosis; of these, 115 patients underwent LH and 388 patients underwent AH. Surgical outcomes-including operative time, blood loss, length of hospital stay, and need for blood transfusion-were analyzed and compared between the 2 treatment groups.
RESULTS: Operative time was significantly longer for LH than for AH (185.1 ± 48.7 minutes and 139.9 ± 52.4 minutes, respectively; P<0.001). However, estimated volume of blood loss, length of hospital stay, and complication rates were significantly less for patients in the LH group than for those in the AH group (302.6 ± 255.1 mL versus 760.9 ± 633.2 mL [P<0.001]; 3.5 ± 1.1 days versus 6.4 ± 3.0 days [P<0.001]; and 18.3% versus 49.0% [P<0.001], respectively).
CONCLUSION: Compared with AH, LH was associated with fewer complications. LH should, therefore, be the preferred surgical option for women with severe pelvic endometriosis who require a hysterectomy.
Copyright © 2011 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22093496     DOI: 10.1016/j.ijgo.2011.09.022

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  8 in total

1.  Evaluation of the American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator in Gynecologic Oncology Patients Undergoing Minimally Invasive Surgery.

Authors:  Deanna Teoh; Rebi Nahum Halloway; Jennifer Heim; Rachel Isaksson Vogel; Colleen Rivard
Journal:  J Minim Invasive Gynecol       Date:  2016-10-24       Impact factor: 4.137

2.  Feasibility of Laparoscopic Hysterectomy in Stage IV Pelvic Endometriosis: Our Technique and Outcomes.

Authors:  Devi Balasubramaniam; Kavitha Yogini Duraisamy; Palanivelu Chinnusamy; Swathi Nethaji; Sangeetha Karunanithi
Journal:  J Midlife Health       Date:  2020-05-04

3.  Effect of Intraperitoneal Bupivacaine on Postoperative Pain in the Gynecologic Oncology Patient.

Authors:  Colleen Rivard; Rachel Isaksson Vogel; Deanna Teoh
Journal:  J Minim Invasive Gynecol       Date:  2015-07-26       Impact factor: 4.137

4.  Use of Chinese medicine correlates negatively with the consumption of conventional medicine and medical cost in patients with uterine fibroids: a population-based retrospective cohort study in Taiwan.

Authors:  Shan-Yu Su; Chih-Hsin Muo; Donald E Morisky
Journal:  BMC Complement Altern Med       Date:  2015-04-23       Impact factor: 3.659

Review 5.  Recurrence of endometriosis after hysterectomy.

Authors:  B Rizk; A S Fischer; H A Lotfy; R Turki; H A Zahed; R Malik; C P Holliday; A Glass; H Fishel; M Y Soliman; D Herrera
Journal:  Facts Views Vis Obgyn       Date:  2014

6.  Radical Surgery for Endometriosis: Analysis of Quality of Life and Surgical Procedure.

Authors:  Cristina M De la Hera-Lazaro; Jose L Muñoz-González; Reyes Oliver Perez; Rocío Vellido-Cotelo; Alvaro Díez-Álvarez; Leticia Muñoz-Hernando; Carmen Alvarez-Conejo; Jesús S Jiménez-López
Journal:  Clin Med Insights Womens Health       Date:  2016-03-07

7.  Completion of vaginal hysterectomy by electro surgery using anteroposterior approach in benign cases faced with obliterated posterior cul-de-sac.

Authors:  Ramkrishna Purohit; Jay Gopal Sharma; Devajani Meher; Sanjay Raosaheb Rakh; Surya Malik
Journal:  Int J Womens Health       Date:  2018-09-17

8.  Use of chinese medicine and subsequent surgery in women with uterine fibroid: a retrospective cohort study.

Authors:  Shan-Yu Su; Chih-Hsin Muo; Donald E Morisky
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-16       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.